Paper8551603
Mutational analysis of human papillomavirus type 16 E6 demonstrates that p53 degradation is necessary for immortalization of mammary epithelial cells.
Dalal S and 3 others. J Virol, 1996. Cited by 88 papers, by iCite.
Cite this record
ConductScience Library. Mutational analysis of human papillomavirus type 16 E6 demonstrates that p53 degradation is necessary for immortalization of mammary epithelial cells. Papers, record 8551603. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8551603
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Transformation, Viral | Major topic |
| Oncogene Proteins, Viral | Major topic |
| Papillomaviridae | Major topic |
| Repressor Proteins | Major topic |
| Tumor Suppressor Protein p53 | Major topic |
| Base Sequence | |
| Breast | |
| Cell Line | |
| DNA Primers | |
| Epithelial Cells | |
| Female | |
| Humans | |
| Molecular Sequence Data | |
| Mutagenesis | |
| Protein Binding | |
| Temperature |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 CA 44174 | NCI NIH HHS | United States | R01CA044174 | PubMed and NIH | NIH RePORTER |
| R01 CA64823 | NCI NIH HHS | United States | R01CA064823 | PubMed and NIH | NIH RePORTER |
| R29 CA56803 | NCI NIH HHS | United States | R29CA056803 | PubMed and NIH | NIH RePORTER |
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7923592 | Tumor cell-specific loss of p53 protein in a unique in vitro model of human breast tumor progression. | Carcinogenesis | 1994 | https://conductscience.org/library/papers/7923592 | PubMed |
| 2 | 8090726 | Identification of a human ubiquitin-conjugating enzyme that mediates the E6-AP-dependent ubiquitination of p53. | Proc Natl Acad Sci U S A | 1994 | https://conductscience.org/library/papers/8090726 | PubMed |
| 3 | 7537374 | Immortalization of distinct human mammary epithelial cell types by human papilloma virus 16 E6 or E7. | Proc Natl Acad Sci U S A | 1995 | https://conductscience.org/library/papers/7537374 | PubMed |
| 4 | 7624774 | Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein. | Science | 1995 | https://conductscience.org/library/papers/7624774 | PubMed |
| 5 | 3036495 | Identification of the HPV-16 E6 protein from transformed mouse cells and human cervical carcinoma cell lines. | EMBO J | 1987 | https://conductscience.org/library/papers/3036495 | PubMed |
| 6 | 2536832 | Identification of human papillomavirus type 18 transforming genes in immortalized and primary cells. | J Virol | 1989 | https://conductscience.org/library/papers/2536832 | PubMed |
| 7 | 2919173 | Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types. | Proc Natl Acad Sci U S A | 1989 | https://conductscience.org/library/papers/2919173 | PubMed |
| 8 | 2476573 | The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. | J Virol | 1989 | https://conductscience.org/library/papers/2476573 | PubMed |
| 9 | 2555178 | HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. | EMBO J | 1989 | https://conductscience.org/library/papers/2555178 | PubMed |
| 10 | 2556677 | The E6 and E7 genes of HPV-18 are sufficient for inducing two-stage in vitro transformation of human keratinocytes. | Oncogene | 1989 | https://conductscience.org/library/papers/2556677 | PubMed |
| 11 | 2153303 | Human papilloma virus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements. | Proc Natl Acad Sci U S A | 1990 | https://conductscience.org/library/papers/2153303 | PubMed |
| 12 | 2157286 | Association of human papillomavirus types 16 and 18 E6 proteins with p53. | Science | 1990 | https://conductscience.org/library/papers/2157286 | PubMed |
| 13 | 2631796 | Improved retroviral vectors for gene transfer and expression. | Biotechniques | 1989 | https://conductscience.org/library/papers/2631796 | PubMed |
| 14 | 2228312 | Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro. | Int J Cancer | 1990 | https://conductscience.org/library/papers/2228312 | PubMed |
| 15 | 1978757 | Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. | Science | 1990 | https://conductscience.org/library/papers/1978757 | PubMed |
| 16 | 2259385 | Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. | Nature | 1990 | https://conductscience.org/library/papers/2259385 | PubMed |
| 17 | 2175676 | The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. | Cell | 1990 | https://conductscience.org/library/papers/2175676 | PubMed |
| 18 | 1845889 | In vitro biological activities of the E6 and E7 genes vary among human papillomaviruses of different oncogenic potential. | J Virol | 1991 | https://conductscience.org/library/papers/1845889 | PubMed |
| 19 | 1845902 | The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. | J Virol | 1991 | https://conductscience.org/library/papers/1845902 | PubMed |
| 20 | 1651408 | The full-length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in culture. | J Virol | 1991 | https://conductscience.org/library/papers/1651408 | PubMed |
Cited by42
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 88 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34217322 | Reciprocal transactivation of Merkel cell polyomavirus and high-risk human papillomavirus promoter activities and increased expression of their oncoproteins. | Virol J | 2021 | https://conductscience.org/library/papers/34217322 | PubMed |
| 33468698 | Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody. | mBio | 2021 | https://conductscience.org/library/papers/33468698 | PubMed |
| 31426742 | In silico prediction of structural changes in human papillomavirus type 16 (HPV16) E6 oncoprotein and its variants. | BMC Mol Cell Biol | 2019 | https://conductscience.org/library/papers/31426742 | PubMed |
| 30971468 | Human Papillomavirus 11 Early Protein E6 Activates Autophagy by Repressing AKT/mTOR and Erk/mTOR. | J Virol | 2019 | https://conductscience.org/library/papers/30971468 | PubMed |
| 29998190 | Preclinical Development of Oncolytic Immunovirotherapy for Treatment of HPVPOS Cancers. | Mol Ther Oncolytics | 2018 | https://conductscience.org/library/papers/29998190 | PubMed |
| 29342959 | Structural Insights in Multifunctional Papillomavirus Oncoproteins. | Viruses | 2018 | https://conductscience.org/library/papers/29342959 | PubMed |
| 28886384 | HPV16 E7 Genetic Conservation Is Critical to Carcinogenesis. | Cell | 2017 | https://conductscience.org/library/papers/28886384 | PubMed |
| 28515303 | Spontaneous and Vaccine-Induced Clearance of Mus Musculus Papillomavirus 1 Infection. | J Virol | 2017 | https://conductscience.org/library/papers/28515303 | PubMed |
| 28166181 | DNA Vaccine Encoding HPV16 Oncogenes E6 and E7 Induces Potent Cell-mediated and Humoral Immunity Which Protects in Tumor Challenge and Drives E7-expressing Skin Graft Rejection. | J Immunother | 2017 | https://conductscience.org/library/papers/28166181 | PubMed |
| 26783529 | Mutagenic Potential ofBos taurus Papillomavirus Type 1 E6 Recombinant Protein: First Description. | Biomed Res Int | 2015 | https://conductscience.org/library/papers/26783529 | PubMed |
| 25789055 | Immunization with mutant HPV16 E7 protein inhibits the growth of TC-1 cells in tumor-bearing mice. | Oncol Lett | 2015 | https://conductscience.org/library/papers/25789055 | PubMed |
| 25031356 | High-risk human papillomavirus E6 protein promotes reprogramming of Fanconi anemia patient cells through repression of p53 but does not allow for sustained growth of induced pluripotent stem cells. | J Virol | 2014 | https://conductscience.org/library/papers/25031356 | PubMed |
| 24594273 | Control of HPV-associated tumors by innovative therapeutic HPV DNA vaccine in the absence of CD4+ T cells. | Cell Biosci | 2014 | https://conductscience.org/library/papers/24594273 | PubMed |
| 24376816 | Structure based identification and characterization of flavonoids that disrupt human papillomavirus-16 E6 function. | PLoS One | 2013 | https://conductscience.org/library/papers/24376816 | PubMed |
| 23711382 | Papillomavirus E6 oncoproteins. | Virology | 2013 | https://conductscience.org/library/papers/23711382 | PubMed |
| 22284986 | Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses. | Virology | 2012 | https://conductscience.org/library/papers/22284986 | PubMed |
| 21672263 | Immunogenicity in mice and rhesus monkeys vaccinated with recombinant vaccinia virus expressing bivalent E7E6 fusion proteins from human papillomavirus types 16 and 18. | Virol J | 2011 | https://conductscience.org/library/papers/21672263 | PubMed |
| 20702634 | MicroRNA 203 expression in keratinocytes is dependent on regulation of p53 levels by E6. | J Virol | 2010 | https://conductscience.org/library/papers/20702634 | PubMed |
| 20383192 | The immortalizing and transforming ability of two common human papillomavirus 16 E6 variants with different prevalences in cervical cancer. | Oncogene | 2010 | https://conductscience.org/library/papers/20383192 | PubMed |
| 19722895 | Therapeutic HPV DNA vaccines. | Expert Rev Vaccines | 2009 | https://conductscience.org/library/papers/19722895 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8551603
GET https://conductscience.org/api/papers/v1/8551603/references?page=2